Data, disease and diplomacy: GISAID's innovative contribution to global health

Elbe, Stefan, Buckland‐Merrett, Gemma·2017·Global Challenges
DOI 10.1002/gch2.1018

Cited by (1,005)

Items 401–500 of 1,005

  1. The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron
    Tanner Wiegand, Artem A. Nemudryi, Anna Nemudraia, Aidan McVey, Agusta Little, David N. Taylor, Seth T. Walk, Blake Wiedenheft · 2022 · Viruses
  2. The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape
    Darren P Martin, Steven Weaver, Houryiah Tegally, Emmanuel James San, Stephen D. Shank, Eduan Wilkinson, Alexander G. Lucaci, Jennifer Giandhari, Sureshnee Naidoo, Yeshnee Pillay et al. · 2021 · PubMed
  3. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients
    Andrew D. Marques, Jevon Graham-Wooten, Ayannah S. Fitzgerald, Ashley Sobel Leonard, Emma J. Cook, J.K. Everett, Kyle G. Rodino, Louise H. Moncla, Brendan J. Kelly, Ronald G. Collman et al. · 2024 · mBio
  4. A review on viral data sources and search systems for perspective mitigation of COVID-19
    Anna Bernasconi, Arif Canakoglu, Marco Masseroli, Pietro Pinoli, Stefano Ceri · 2020 · Briefings in Bioinformatics
  5. Evolutionary analysis and lineage designation of SARS-CoV-2 genomes
    Xiaolu Tang, Ruochen Ying, Xinmin Yao, Guanghao Li, Changcheng Wu, Yiyuli Tang, Zhida Li, Bishan Kuang, Feng Ying Wu, Changsheng Chi et al. · 2021 · 中国科学通报：英文版
  6. Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand
    Jemma L. Geoghegan, Jordan Douglas, Xiaoyun Ren, Matthew Storey, James Hadfield, Olin Silander, Nikki E. Freed, Lauren Jelley, Sarah Jefferies, Jillian Sherwood et al. · 2021 · Emerging infectious diseases
  7. Increase of SARS-CoV-2 RNA load in faecal samples prompts for rethinking of SARS-CoV-2 biology and COVID-19 epidemiology
    Mauro Petrillo, Carlo Brogna, Simone Cristoni, Maddalena Querci, Ornella Piazza, Guy Van den Eede · 2021 · F1000Research
  8. Emerging mutations in envelope protein of SARS-CoV-2 and their effect on thermodynamic properties
    Kejie Mou, Mohnad Abdalla, Dong Qing Wei, Muhammad Tahir Khan, Madeeha Shahzad Lodhi, Doaa Bahaa Eldin Darwish, Mohamed Sharaf, Xudong Tu · 2021 · Informatics in Medicine Unlocked
  9. HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation
    Daixi Li, Peiqin Chen, Ting Shi, Aamir Mehmood, Jingfei Qiu · 2021 · Interdisciplinary Sciences Computational Life Sciences
  10. VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
    Wasim Aluísio Prates-Syed, Lorena C. S. Chaves, Karin P. Crema, Larissa Vuitika, Aline Aparecida de Lima Lira, Nelson Côrtes, Victor Kersten, Francisco Eduardo Gontijo Guimarães, Mohammad Sadraeian, Fernando Luís Barroso da Silva et al. · 2021 · Vaccines
  11. Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial
    Rolando Pajón, Yamuna Devi Paila, Bethany Girard, Groves Dixon, Katherine A. Kacena, Lindsey Robert Baden, Hana M. El Sahly, Brandon J. Essink, Kathleen M. Mullane, Ian Frank et al. · 2022 · Nature Medicine
  12. Rapid evolution of SARS-CoV-2 challenges human defenses
    Carlos Manuel Duarte, David I. Ketcheson, Victor M. Eguı́luz, Susana Agustı́, Juan Fernández-Gracia, Tahira Jamil, Elisa Laiolo, Takashi Gojobori, Intikhab S. Alam · 2022 · Scientific Reports
  13. Reverse-zoonotic transmission of SARS-CoV-2 lineage alpha (B.1.1.7) to great apes and exotic felids in a zoo in the Czech Republic
    Alexander Nagy, Martina Stará, Roman Vodička, Lenka Černíková, Helena Jiřincová, Vlastimil Křivda, Kamil Sedlák · 2022 · Archives of Virology
  14. Mutations in SARS-CoV-2 are on the increase against the acquired immunity
    Tomokazu Konishi · 2022 · PLoS ONE
  15. Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination
    Esteban Aznar, Inmaculada Casas, Alejandro González Praetorius, María José Ruano Ramos, Francisco Pozo, María José Sierra Moros, María Victoria García Rivera, Azucena Sánchez Sánchez, Elena García-Villacieros, Gabriela Saravia et al. · 2023 · Eurosurveillance
  16. SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?
    Shing H. Zhan, Benjamin E. Deverman, Yujia A. Chan · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  17. Biothermodynamics of Viruses from Absolute Zero (1950) to Virothermodynamics (2022)
    Marko E. Popovic · 2022 · Vaccines
  18. Quantifying within-host diversity of H5N1 influenza viruses in humans and poultry in Cambodia
    Louise H. Moncla, Trevor Bedford, Philippe Dussart, Srey Viseth Horm, Sareth Rith, Philippe Buchy, Erik A. Karlsson, Lifeng Li, Yongmei Liu, Huachen Zhu et al. · 2020 · PLoS Pathogens
  19. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro
    Fabrizio Pucci, Marianne J. Rooman · 2021 · Viruses
  20. Variants in SARS-CoV-2 associated with mild or severe outcome
    Jameson D. Voss, Martin Skarzynski, Erin M. McAuley, Ezekiel J. Maier, Thomas F. Gibbons, Anthony C Fries, Richard R. Chapleau · 2021 · Evolution Medicine and Public Health
  21. The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
    Tiziana Ginex, Clara Marco‐Marín, Miłosz Wieczór, Carlos P. Mata, James Krieger, Paula Ruiz-Rodríguez, Maria Lopez-Redondo, Clara Francés‐Gómez, Roberto Melero, Carlos Óscar S. Sorzano et al. · 2022 · PLoS Pathogens
  22. Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
    Kexin Yan, Troy D. Dumenil, Bing Tang, Thuy T. Le, Cameron Bishop, Andreas Suhrbier, Daniel J. Rawle · 2022 · Virus Evolution
  23. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants
    Chao Su, Juanhua He, Pengcheng Han, Bin Bai, Dedong Li, Jian Xin Cao, Mingxiong Tian, Yu Hu, Anqi Zheng, Sheng Niu et al. · 2022 · Journal of Virology
  24. SARS-CoV-2 variants: Impact on biological and clinical outcome
    Shakuntala Mahilkar, Sachee R Agrawal, Sakshi Chaudhary, Swapneil Parikh, Subash Chandra Sonkar, Dileep Kumar Verma, Vidushi Chitalia, Divya Mehta, Bidhan Chandra Koner, Neetu Vijay et al. · 2022 · Frontiers in Medicine
  25. Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City
    Alberto Cedro‐Tanda, Laura Gómez-Romero, Guillermo de Anda‐Jáuregui, Dora Garnica-López, Yair Alfaro‐Mora, Sonia Sánchez-Xochipa, Eulices F. García-García, Alfredo Mendoza-Vargas, Emmanuel Frías-Jiménez, Bernardo Moreno et al. · 2022 · Viruses
  26. Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein
    Ziqi Feng, Jiachen Huang, Sabyasachi Baboo, Jolene K. Diedrich, Sandhya Bangaru, James C. Paulson, John R. Yates, Meng Yuan, Ian A. Wilson, Andrew B. Ward · 2025 · Cell Reports
  27. Cancer Research: The Lessons to Learn from COVID-19
    Chris Bailey, James R. Black, Charles Swanton · 2020 · Cancer Discovery
  28. Accelerating ophthalmic artificial intelligence research: the role of an open access data repository
    Ashley Kras, Leo Anthony Celi, John B. Miller · 2020 · Current Opinion in Ophthalmology
  29. Identification of Novel Candidate Epitopes on SARS-CoV-2 Proteins for South America: A Review of HLA Frequencies by Country
    David Requena, Aldhair Médico, Ruy D. Chacón, Manuel Ramírez, Obert Marín-Sánchez · 2020 · Frontiers in Immunology
  30. Infection with different strains of SARS-COV-2 in patients with COVID-19
    Hayder Obayes Hashim, Mudher Mohammed, Mazin Jaafar Mousa, Hadeer H. Abdulameer, Alaa Tareq Shakir Al-Hassnawi, Safa A. Hassan, Mohammed Baqur S. Al‐Shuhaib · 2020 · Archives of Biological Sciences
  31. Profiling SARS-CoV-2 mutation fingerprints that range from the viral pangenome to individual infection quasispecies
    Billy T. Lau, Dmitri S. Pavlichin, Anna C. Hooker, Alison Figueroa Almeda, Gi Won Shin, Jiamin Chen, Malaya Kumar Sahoo, ChunHong Huang, Benjamin A. Pinsky, HoJoon Lee et al. · 2021 · Genome Medicine
  32. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern
    Tiago Gräf, Gonzalo Bello, Tainá Moreira Martins Venas, Elisa Cavalcante Pereira, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, Alice Sampaio Barreto da Rocha, Fernando Couto Motta et al. · 2021 · Virus Evolution
  33. Detection of SARS‐CoV‐2 clade B.1.2 in three snow leopards
    Leyi Wang, Zoltan S. Gyimesi, Mary Lea Killian, Mia Kim Torchetti, Colleen A. Olmstead, Richard L. Fredrickson, Karen A. Terio · 2022 · Transboundary and Emerging Diseases
  34. XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2
    Marko E. Popovic · 2023 · Microbiological Research
  35. Inferring effects of mutations on SARS-CoV-2 transmission from genomic surveillance data
    Brian Lee, Ahmed Abdul Quadeer, Muhammad Saqib Sohail, Elizabeth Finney, Syed Faraz Ahmed, Matthew R. McKay, John P. Barton · 2025 · Nature Communications
  36. Exploring dynamics and network analysis of spike glycoprotein of SARS-COV-2
    Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda · 2021 · Biophysical Journal
  37. Genomic characterization of SARS‐CoV‐2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins
    Erdem Şahin, Gülendam Bozdayı, Selin Yiğit, Hager Muftah, Murat Dizbay, Özlem Güzel Tunçcan, Işıl Fidan, Kayhan Çağlar · 2021 · Journal of Medical Virology
  38. Correlated sequence signatures are present within the genomic 5′UTR RNA and NSP1 protein in coronaviruses
    Piotr Sosnowski, Antonin Tidu, Gilbert Eriani, Éric Westhof, Franck Martin · 2022 · RNA
  39. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand
    Lauren Jelley, Jordan Douglas, Xiaoyun Ren, David J. Winter, Andrea McNeill, Q. Sue Huang, Nigel Peter French, David Welch, James Hadfield, Joep de Ligt et al. · 2022 · Nature Communications
  40. Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand
    Jemma L. Geoghegan, Xiaoyun Ren, Matthew Storey, James Hadfield, Lauren Jelley, Sarah Jefferies, Jill Sherwood, Shevaun Paine, Q. Sue Huang, Jordan Douglas et al. · 2020 · medRxiv
  41. Predicting the mutational drivers of future SARS-CoV-2 variants of concern
    M. Cyrus Maher, István Bartha, Steven Weaver, Julia di Iulio, Elena Ferri, Leah B. Soriaga, Florian A. Lempp, Brian Hie, Bryan D. Bryson, Bonnie Berger et al. · 2021 · DSpace@MIT (Massachusetts Institute of Technology)
  42. Genomic surveillance of SARS-CoV-2 Spike gene by sanger sequencing
    Tiago Souza Salles, Andréa Cony Cavalcanti, Fábio Burack da Costa, Vanessa Zaquieu Dias, Leandro Magalhães de Souza, Marcelo Damião Ferreira de Meneses, José Antônio Suzano da Silva, Cinthya Domingues Amaral, Jhonatan Ramos Felix, Duleide Alves Pereira et al. · 2022 · PLoS ONE
  43. Gender Differences in Response to COVID-19 Infection and Vaccination
    Kawther A. Zaher, Fatemah Salem Basingab, Jehan Alrahimi, Kholood Basahel, Alia Aldahlawi · 2023 · Biomedicines
  44. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study
    Boxiang Liu, Kaibo Liu, He Zhang, Liang Zhang, Yuchen Bian, Liang Huang · 2020 · Journal of Medical Internet Research
  45. Antigenic variation of SARS‐CoV‐2 in response to immune pressure
    Diego Forni, Rachele Cagliani, Chiara Pontremoli, Alessandra Mozzi, Uberto Pozzoli, Mario Clerici, Manuela Sironi · 2020 · Molecular Ecology
  46. Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa
    Malik Sallam, Nidaa A. Ababneh, Deema Dababseh, Faris Ghalib Bakri, Azmi M. Mahafzah · 2021 · Heliyon
  47. Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant
    Marielle Bedotto, Pierre‐Edouard Fournier, Linda Houhamdi, Anthony Levasseur, Jérémy Delerce, Lucile Pinault, Abdou Padane, Amanda Chamieh, Hervé Tissot‐Dupont, Philippe Brouqui et al. · 2021 · Journal of Clinical Virology
  48. Molecular Epidemiology of SARS-CoV-2 in Tunisia (North Africa) through Several Successive Waves of COVID-19
    Anissa Chouikha, Wasfi Farès, Asma Lamari, S Boubaker, Zeineb Belaiba, Kaïs Ghedira, Wafa Kammoun Rebai, Kaouther Ayouni, Marwa Khedhiri, Samar Ben Halima et al. · 2022 · Viruses
  49. Estimating the strength of selection for new SARS-CoV-2 variants
    Christiaan Hendrik van Dorp, Emma E. Goldberg, Nicolas Hengartner, Ruian Ke, Ethan Obie Romero-Severson · 2021 · Nature Communications
  50. SARS-CoV-2 Membrane Protein: From Genomic Data to Structural New Insights
    Catarina Marques-Pereira, Manuel Pires, Raquel P. Gouveia, Nádia N. Pereira, Ana B. Caniceiro, Nícia Rosário‐Ferreira, Irina Sousa Moreira · 2022 · International Journal of Molecular Sciences
  51. Alterations in SARS-CoV-2 Omicron and Delta peptides presentation by HLA molecules
    Stepan A. Nersisyan, Anton Zhiyanov, Maria Zakharova, Irina A. Ishina, Inna N. Kurbatskaia, Azad E. Mamedov, Alexei Vladimirovich Galatenko, M. Yu. Shkurnikov, Alexander G. Gabibov, Alexander Tonevitsky · 2022 · PeerJ
  52. Modelling COVID-19 vaccine breakthrough infections in highly vaccinated Israel—The effects of waning immunity and third vaccination dose
    Anyin Feng, Uri Obolski, Lewi Stone, Daihai He · 2022 · PLOS Global Public Health
  53. Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies
    Daniel J. Sheward, Pradeepa Pushparaj, Hrishikesh Das, Allison J. Greaney, Changil Kim, Sungyong Kim, Leo Hanke, Erik Hyllner, Robert Dyrdak, Jimin Lee et al. · 2024 · Cell Reports Medicine
  54. Structural and Functional Comparison of SARS-CoV-2-Spike Receptor Binding Domain Produced in Pichia pastoris and Mammalian Cells
    Claudia R. Arbeitman, Gabriela Alejandra Auge, Matı́as Blaustein, Luis M. Bredeston, Enrique Corapi, Patricio O. Craig, Leandro A. Cossio, Liliana Daín, Cecilia D’Alessio, Fernanda Elias et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  55. Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic
    Philippe Colson, Hervé Chaudet, Jérémy Delerce, Pierre Pontarotti, Anthony Levasseur, Jacques Fantini, Bernard La Scola, Christian Albert Devaux, Didier Raoult · 2024 · Journal of Infection
  56. Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19
    Gourab Das, Troyee Das, Nilkanta Chowdhury, Durbadal Chatterjee, Angshuman Bagchi, Zhumur Ghosh · 2020 · Genomics
  57. Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020
    Ae Kyung Park, Il‐Hwan Kim, Junyoung Kim, Jeong‐Min Kim, Heui Man Kim, Chae Young Lee, Myung Guk Han, Gi‐eun Rhie, Donghyok Kwon, Jeong‐Gu Nam et al. · 2021 · Osong Public Health and Research Perspectives
  58. Exploring the Regulatory Function of the N‐terminal Domain of SARS‐CoV‐2 Spike Protein through Molecular Dynamics Simulation
    Yao Li, Tong Wang, Juanrong Zhang, Bin Shao, Haipeng Gong, Yusong Wang, Xinheng He, Siyuan Liu, Tie‐Yan Liu · 2021 · Advanced Theory and Simulations
  59. The Runaway Evolution of SARS-CoV-2 Leading to the Highly Evolved Delta Strain
    Yongsen Ruan, Mei Hou, Xiaolu Tang, Xionglei He, Xuemei Lu, Jian Lü, Chung‐I Wu, Haijun Wen · 2022 · Molecular Biology and Evolution
  60. Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants
    Claudia Del Vecchio, Bethan Cracknell Daniels, Giuseppina Brancaccio, Alessandra Rosalba Brazzale, Enrico Lavezzo, Constanze Ciavarella, Francesco Onelia, Elisa Franchin, Laura Manuto, Federico Bianca et al. · 2022 · Nature Communications
  61. Never ending story? Evolution of SARS-CoV-2 monitored through Gibbs energies of biosynthesis and antigen-receptor binding of Omicron BQ.1, BQ.1.1, XBB and XBB.1 variants
    Marko E. Popovic · 2023 · Microbial Risk Analysis
  62. Incorporating variant frequencies data into short-term forecasting for COVID-19 cases and deaths in the USA: a deep learning approach
    Hongru Du, Ensheng Dong, Hamada S. Badr, Mary E. Petrone, Nathan D. Grubaugh, Lauren Gardner · 2023 · EBioMedicine
  63. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
    Ryuta Uraki, Shun Iida, Peter Halfmann, Seiya Yamayoshi, Yuichiro Hirata, Kiyoko Iwatsuki‐Horimoto, Maki Kiso, Mutsumi Ito, Yuri Furusawa, Hiroshi Ueki et al. · 2023 · Nature Communications
  64. MicroGMT: A Mutation Tracker for SARS-CoV-2 and Other Microbial Genome Sequences
    Yue Xing, Xiao Li, Xiang Gao, Qunfeng Dong · 2020 · Frontiers in Microbiology
  65. Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations
    Nicholas J Dimonaco, Mazdak Salavati, Barbara Bo-Ju Shih · 2020 · Viruses
  66. Developing effective siRNAs to reduce the expression of key viral genes of COVID-19
    Renfei Wu, Kathy Qian Luo · 2021 · International Journal of Biological Sciences
  67. High throughput diagnostics and dynamic risk assessment of SARS-CoV-2 variants of concern
    Alfredo Maria Gravagnuolo, Layla Faqih, Cara Cronshaw, Jackie Wynn, Lewis Burglin, Paul E. Klapper, Mark J Wigglesworth · 2021 · EBioMedicine
  68. Variation at Spike position 142 in SARS-CoV-2 Delta genomes is a technical artifact caused by dropout of a sequencing amplicon
    Theo Sanderson, Jeffrey C. Barrett · 2021 · Wellcome Open Research
  69. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions
    Mariona Torrens‐Fontanals, Alejandro Peralta-García, Carmine Talarico, Ramón Guixà-González, Toni Giorgino A, Jana Selent · 2021 · Nucleic Acids Research
  70. Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 M pro and its evolutionary mutations as a case study
    Olivier Sheik Amamuddy, Rita Afriyie Boateng, Victor Barozi, Dorothy Wavinya Nyamai, Özlem Taştan Bishop · 2021 · Computational and Structural Biotechnology Journal
  71. Rescuing low frequency variants within intra-host viral populations directly from Oxford Nanopore sequencing data
    Yunxi Liu, Joshua Kearney, Medhat Mahmoud, Bryce L. Kille, Fritz Joachim Sedlazeck, Todd J. Treangen · 2022 · Nature Communications
  72. Three-Dimensional Visualization of Viral Structure, Entry, and Replication Underlying the Spread of SARS-CoV-2
    James W. Saville, Alison Berezuk, Shanti Swaroop Srivastava, Sriram Subramaniam · 2022 · Chemical Reviews
  73. Genomic evidence for divergent co-infections of co-circulating SARS-CoV-2 lineages
    Hangyu Zhou, Ye‐Xiao Cheng, Lin Sen Xu, Jia-Ying Li, Chenyue Tao, Chengyang Ji, Na Han, Rong Yang, Hui Ming Wu, Yaling Li et al. · 2022 · Computational and Structural Biotechnology Journal
  74. Phylodynamics of SARS-CoV-2 transmission in Spain
    Francisco Díez‐Fuertes, María Iglesias‐Caballero, Sara Monzón, Pilar Jiménez, Sarai Varona, Isabel Cuesta, Ángel Zaballos, Michael M. Thomson, Mercedes Jiménez, Javier García‐Pérez et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
    Satoshi Ikegame, Mohammed Nure Alam Siddiquey, Chuan-Tien Hung, Griffin D. Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, Ariel Esteban Vilardo, Alexis Edelstein, Claudia Perandones et al. · 2021 · medRxiv
  76. Rapid characterization of a Delta-Omicron SARS-CoV-2 recombinant detected in Europe
    Etienne Simon‐Lorière, Xavier Montagutelli, Frederic Lemoine, Flora Donati, Franck Touret, Jérôme Bourret, Matthieu Prot, Sandie Munier, Mikaël Attia, Laurine Conquet et al. · 2022 · Research Square
  77. The Case for Genomic Surveillance in Africa
    Rachel Ochola · 2025 · Tropical Medicine and Infectious Disease
  78. PACIFIC: a lightweight deep-learning classifier of SARS-CoV-2 and co-infecting RNA viruses
    Pablo Acera Mateos, Renzo F. Balboa, Simon Easteal, Eduardo Eyras, Hardip R. Patel · 2021 · Scientific Reports
  79. Genomic surveillance activities unveil the introduction of the SARS‐CoV‐2 B.1.525 variant of interest in Brazil: Case report
    Felicidade Mota Pereira, Stephane Fraga de Oliveira Tosta, Maricélia Maia de Lima, Luciana Reboredo de Oliveira da Silva, Vanessa Brandão Nardy, Marcela Gómez, Jaqueline Gomes Lima, Vagner Fonseca, Túlio de Oliveira, José Lourenço et al. · 2021 · Journal of Medical Virology
  80. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
    Yu Kaku, Takeo Kuwata, Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, Shashwata Biswas, Kaho Matsumoto, Mikiko Shimizu, Yoko Kawanami et al. · 2021 · Cell Reports
  81. Monitoring the SARS-CoV-2 pandemic: screening algorithm with single nucleotide polymorphism detection for the rapid identification of established and emerging variants
    Joachim C. Mertens, Jasmine Coppens, Katherine Loens, Marie Le Mercier, Basil Britto Xavier, Christine Lammens, Sarah Vandamme, Hilde Jansens, Herman Goossens, Veerle Matheeussen · 2021 · Clinical Microbiology and Infection
  82. Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability
    Kejie Mou, Farwa Mukhtar, Muhammad Tahir Khan, Doaa Bahaa Eldin Darwish, Shaoliang Peng, Shabbir Muhammad, Abdullah Godran Al-Sehemi, Dong‐Qing Wei · 2021 · Pathogens
  83. Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method
    Sungbo Hwang, Seung‐Hwa Baek, Daeui Park · 2022 · Journal of Chemical Information and Modeling
  84. Genomic Epidemiology of SARS-CoV-2 Divulge B.1, B.1.36, and B.1.1.7 as the Most Dominant Lineages in First, Second, and Third Wave of SARS-CoV-2 Infections in Pakistan
    Atia Basheer, Imran Zahoor · 2021 · Microorganisms
  85. Genomic surveillance of SARS-CoV-2 Omicron variants on a university campus
    Ana A. Weil, Kyle G Luiten, Amanda M. Casto, Julia Catherine Bennett, Jessica O’Hanlon, Peter D. Han, Luis S. Gamboa, Evan McDermot, Melissa Truong, Geoffrey S. Gottlieb et al. · 2022 · Nature Communications
  86. Evolutionary rate of SARS-CoV-2 increases during zoonotic infection of farmed mink
    Ashleigh F. Porter, Damian F. J. Purcell, Benjamin P. Howden, Sebastián Duchêne · 2023 · Virus Evolution
  87. Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
    Idowu B. Olawoye, Paul E. Oluniyi, Judith Uche Oguzie, Jessica N. Uwanibe, Adeyemi T. Kayode, Testimony Jesupamilerin Olumade, Fehintola Victoria Ajogbasile, Edyth Parker, Philomena Eromon, Priscilla Abechi et al. · 2023 · Nature Communications
  88. The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity
    Hazel Stewart, Yongxu Lu, Sarah M. O’Keefe, Anusha Valpadashi, Luis Daniel Cruz‐Zaragoza, Hendrik A. Michel, Samantha K. Nguyen, George Carnell, Nina I. Lukhovitskaya, Rachel Milligan et al. · 2023 · iScience
  89. Efficient and robust search of microbial genomes via phylogenetic compression
    Karel Břinda, Leandro Lima, Simone Pignotti, Natalia Quinones‐Olvera, Kamil Salikhov, Rayan Chikhi, Grégory Kucherov, Zamin Iqbal, Michael Baym · 2025 · Nature Methods
  90. Interim Analysis of Pandemic Coronavirus Disease 2019 (COVID-19) and the SARS-CoV-2 virus in Latin America and the Caribbean: Morbidity, Mortality and Molecular Testing Trends in the Region
    Katherine Simbaña‐Rivera, Lenin Gómez‐Barreno, Jhon Guerrero, Fernanda Simbaña-Guaycha, Raúl Fernández, Andrés López‐Cortés, Alex J. J. Lister, Esteban Ortiz‐Prado · 2020 · medRxiv
  91. Analysis of SARS-CoV-2 genome evolutionary patterns
    Shubhangi Gupta, Deepanshu Gupta, Sonika Bhatnagar · 2024 · Microbiology Spectrum
  92. Circumpolar spread of avian influenza H5N1 to southern Indian Ocean islands
    Augustin Clessin, François‐Xavier Briand, J Tornos, Mathilde Lejeune, Camille De Pasquale, Romain Fischer, Florent Souchaud, Edouard Hirchaud, Samuel Leandro Hong, Tristan Bralet et al. · 2025 · Nature Communications
  93. SARS‐CoV‐2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time‐course study – potential challenge for vaccines and therapies
    Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler · 2021 · EMBO Molecular Medicine
  94. Genomic epidemiology of a densely sampled COVID-19 outbreak in China
    Lily Geidelberg, Olivia Boyd, David Jorgensen, Igor A. Siveroni, Fabrícia Ferreira do Nascimento, Robert Johnson, Manon Ragonnet‐Cronin, Han Jing Fu, Haowei Wang, Xiaoyue Xi et al. · 2020 · Virus Evolution
  95. Mutations in the SARS-CoV-2 spike protein modulate the virus affinity to the human ACE2 receptor, an in silico analysis
    Joseph T. Ortega, Flor Helene Pujol, Beata Jastrzębska, Hector Rafael Rangel · 2021 · EXCLI journal
  96. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1
    Armi M Chaudhari, Minal Chaudhari, Sapna Mahera, Zuber Saiyed, Neelam Mustakali Nathani, Shantanu P. Shukla, Dhaval Patel, Chirag Patel, Madhvi N. Joshi, Chaitanya G. Joshi · 2021 · Informatics in Medicine Unlocked
  97. Evolution of viral variants in remdesivir‐treated and untreated SARS‐CoV‐2‐infected pediatrics patients
    Florencia A. T. Boshier, Juanita Pang, Justin Penner, Joseph Hughes, Matthew D. Parker, James Shepherd, Nele Alders, Alasdair Bamford, Louis Grandjean, Stephanie Grünewald et al. · 2021 · Journal of Medical Virology
  98. Decomposing the sources of SARS-CoV-2 fitness variation in the United States
    Lenora M. Kepler, Marco Hamins-Puértolas, David A. Rasmussen · 2021 · Virus Evolution
  99. Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection
    Chee‐Hong Wong, Chew Yee Ngan, Rachel L. Goldfeder, Jennifer Idol, Chris Kuhlberg, Rahul Maurya, Kevin Kelly, Gregory Omerza, Nicholas Renzette, Francine De Abreu et al. · 2021 · Communications Medicine
  100. Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States
    Radhika V. Gharpure, Samira Sami, Johanna Vostok, Hillary Johnson, Noemi Borsay Hall, Anne Foreman, Rebecca T. Sabo, Petra L. Schubert, Hanna M. Shephard, Vance R. Brown et al. · 2021 · Emerging infectious diseases